Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Wee Wendy, Chief Financial Officer. Officer active across 1 company, notably Kindred Biosciences, Inc.. Cumulatively, 2 filings have been logged. History available since 27 August 2021. The latest transaction was filed on 27 August 2021 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Wee Wendy is the Chief Financial Officer at Kindred Biosciences, Inc. She oversees the financial management of the company and ensures regulatory compliance. Wendy plays a crucial role in financial planning and performance analysis to ensure the sustainable growth of the organization.